Aug 27, 2013
The industry’s preeminent event on novel drug targets unites 700+ scientists and technologists for key discussions and connections. The event includes 40+ exhibitors, peer posters and keynote presentations by Stuart Schreiber and Paul Feldman.
Aug 22, 2013
Jack Ragheb, Ph.D., Principal Investigator, Therapeutic Proteins, FDA/CDER to moderate a roundtable discussion at CHI’s Immunogenicity Summit 2013 this coming November at the Hyatt Regency on Capitol Hill in Washington, DC.
Aug 21, 2013
Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.
Aug 05, 2013
Complimentary case study download by Deborah Finco, Ph.D., Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc.
Jul 17, 2013
Drug R&D Scientists Gather to Discuss Complex Cellular Models Predictive of Human Response to Improve Early Decision Making
Jul 16, 2013
Proven assay development and target identification methods to be presented by GSK, Broad, NIH, University of Pittsburg, iRND3, and more this October in Cambridge, MA
Jul 11, 2013
Technologies and Strategies for Safe and Efficacious Products in the Clinic
Jul 09, 2013
Led by global industry pioneers, Clinical Genomics & Informatics Europe will provide research teams with technologies and strategies for Exome Sequencing, High-Scale Computing, RNA Sequencing, Genome Informatics, Epigenetics and Digital Detection.
Jul 08, 2013
In vitro Models of Tumor Microenvironment for New Cancer Target and Drug Discovery
Jul 02, 2013
Taking place October 28-29, 2013 in Cambridge, MA, CHI’s Engineering Functional 3-D Tissue Models Conference will deliver a multidisciplinary approach to creating the more biologically relevant third dimension of tissue models.